Skopos Labs, Inc. Alkermes Plc. Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 1,054 shares of ALKS stock, worth $32,674. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,054
Previous 90
1071.11%
Holding current value
$32,674
Previous $2,000
1600.0%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ALKS
# of Institutions
410Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$902 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$565 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$365 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$249 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$213 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.09B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...